Travelers (NYSE: TRV) EVP Jeffrey Klenk receives 12,854 stock options

Rhea-AI Filing Summary

The Travelers Companies, Inc. executive Jeffrey P. Klenk, EVP & President, Bond & Specialty Insurance, reported an award of stock options. On February 3, 2026, he acquired 12,854 stock options with a $288.23 exercise price, each for one share of common stock.

These options become exercisable on February 3, 2029 and expire on February 3, 2036. Following this grant, Klenk beneficially owns 12,854 derivative securities directly, as reflected in the filing.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Klenk Jeffrey P.

Role EVP & Pres., Bond & Spec. Ins.

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Right to Buy)	12,854	$0.00	$0.00

Holdings After Transaction: Stock Options (Right to Buy) — 12,854 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/05/2026 - 04:27 PM Learn about SEC filing dates

FAQ

What insider transaction did Travelers (TRV) report for Jeffrey P. Klenk?

Jeffrey P. Klenk reported receiving 12,854 stock options of The Travelers Companies, Inc. on February 3, 2026. The options are rights to buy Travelers common stock at a fixed exercise price documented in the filing.

What is the exercise price of Jeffrey P. Klenk’s new Travelers (TRV) stock options?

The stock options granted to Jeffrey P. Klenk have a $288.23 exercise price per share. This is the price at which he can purchase Travelers common stock once the options become exercisable.

When do Jeffrey P. Klenk’s Travelers (TRV) stock options vest and expire?

Jeffrey P. Klenk’s stock options become exercisable on February 3, 2029 and expire on February 3, 2036. After the expiration date, any unexercised options can no longer be used to buy Travelers common stock.

How many Travelers (TRV) derivative securities does Jeffrey P. Klenk own after this Form 4?

After the reported transaction, Jeffrey P. Klenk beneficially owns 12,854 derivative securities, consisting of the newly granted stock options. The filing shows these options as held directly in his name.

What role does Jeffrey P. Klenk hold at Travelers (TRV) in this Form 4?

Jeffrey P. Klenk is identified as an officer of The Travelers Companies, Inc., serving as EVP & President, Bond & Specialty Insurance. His position is disclosed as part of the insider reporting information.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Klenk Jeffrey P.

(Last) (First) (Middle)

THE TRAVELERS COMPANIES, INC.

385 WASHINGTON STREET

(Street)

ST. PAUL MN 55102

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRAVELERS COMPANIES, INC. [ TRV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Pres., Bond & Spec. Ins.

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$288.23	02/03/2026		A		12,854		02/03/2029	02/03/2036	Common Stock	12,854	$0	12,854	D

Explanation of Responses:

	/s/Wendy C. Skjerven, by power of attorney	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.